The Pharmaceutical Market: Turkey

Table of Contents

TURKEY: BACKGROUND DATA

GEOGRAPHY

• Map of Turkey

POLITICAL OVERVIEW

ECONOMIC OVERVIEW

• GDP & Growth, 1995-2006

POPULATION

• Population by Region, 2002-2005 (000s)
• Population by Age, 2005 (000s)

DEMOGRAPHIC INDICATORS

• Demographic Indicators, 2000-2004

MORTALITY

• Registered Deaths by Type, 1999-2003

MORBIDITY

• Notifiable Infectious Diseases, 1999-2004
• Vaccination Coverage of Children Under One Year of Age, 1999-2004 (%)
• HIV/AIDS
  • AIDS Cases and Carriers by Age and Sex, 1985-2004,
  • AIDS Cases, 1995-2004
  • Reported AIDS Cases, 1982-2003
• Cancer
  • Male Cancer by Site, 1999
  • Female Cancer by Site, 1999
  • Cancer Control Programme
• Diabetes
  • National Diabetes Programme
  • Tuberculosis
  • Tuberculosis Cases, 1990-2002

CHARTS

• Population by Age, 2005 (%)

TURKEY: HEALTHCARE SYSTEM

ORGANISATION & ADMINISTRATION

• Health Insurance
• Population Coverage, by Insurance Provider, 1999-2000

HEALTH EXPENDITURE

HOSPITAL SERVICES

• Hospital Resources, 2000-2004
• Hospital Resources by Operator, 2004
• Hospital Activity
  • Hospital Activity Trends, 1998-2004
  • Hospital Discharges by Diagnosis and Sex, 2004
  • Patient Days by Diagnosis and Sex, 2004
  • Inpatient Activity at Ministry of Health Institutions, 2002
  • Hospital Efficiency by Hospital Size, 2000

AMBULATORY CARE

• Outpatient Facilities, 1999-2003
• Visits to Outpatient Facilities by Type of Hospital, 1995-2000
• Utilisation of Non-Public Hospitals, 2000

MEDICAL PERSONNEL

• Physicians by Establishment, 2003
• Other Medical Personnel by Establishment, 2003

CHARTS

• Hospitals by Operator, 2004 (%)
• Beds by Operator, 2004 (%)
• Outpatient Facilities by Type, 2003 (%)

TURKEY: ACCESSING THE PHARMACEUTICAL MARKET

INTRODUCTION

REGULATORY ENVIRONMENT

• OTC Legislation
• Pharmaceutical Registration
  • Section 1: Summary of File
  • Section 2: Chemical, Pharmaceutical and Biological Information
  • Section 3: Toxicological and Pharmacological Information
  • Section 4: Clinical Documentation
  • Generics
  • Data Required for Marketing Authorisation in Turkey
  • Post-marketing Surveillance
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
  • Patient Co-payment Policy
  • New Reimbursement System

DISTRIBUTION CHANNELS

• Distributors

DOMESTIC PRODUCTION

• Pharmaceutical Consumption by Therapeutic Class, 1999-2005 (%)
• Worldwide Top Five Therapeutic Classes (%)
• Pharmaceutical Production, 1999-2003
• Investment in the Pharmaceutical Industry, 1992-2002 (US$ million)
• Trade Associations
  • Pharmaceutical Manufacturer' s Association (IEIS)
  • Domestic Producers
  • Abdi Ibrahim Ilac Sanyi ve Ticaret A.S.
  • Bilim Pharmaceuticals
  • Eczacibasi
  • Embil Pharmaceutical Co. Ltd
  • Fako Ilaçlari A.S
  • Mustafa Nevzat Pharmaceuticals
  • Sanovel
  • Turgut Group

DIRECTORY

• Government Organisations
• Trade Associations